Share
Journal Information
Articles in press
Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info
Malignant transformation in fistula after proctosigmoidectomy: A rare complication of long-standing Crohn's disease
Francisco Vara-Luiz, Ivo Mendes, Ana Elisa Teles, Carla Oliveira, Ana Pascoal, Cláudia Afonso, Marta Patita, Irina Mocanu, ... Jorge Fonseca
10.1016/j.gastrohep.2024.01.012
Available online 24 February 2024
Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine
Guillermo Bastida, Diego Alvarez-Sotomayor, Mariam Aguas, Marisa Iborra, Javier Del Hoyo, Sergio Béjar-Serrano, Alejandro Garrido-Marín, Elena Valero-Pérez, Pilar Nos
10.1016/j.gastrohep.2023.12.001
Available online 23 February 2024
Assessment of the quality, diagnosis, and therapeutic recommendations of clinical practice guidelines on patients with Helicobacter pylori infection: A systematic review
Muyang Li, Xueni Ma, Huimei Xu, Mengyu Han, Lingzhu Gou, Hongwei Du, Lina Wei, Dekui Zhang
10.1016/j.gastrohep.2024.01.006
Available online 22 February 2024
Recomendaciones sobre el manejo de la obesidad grave en pacientes con enfermedad inflamatoria intestinal del Grupo Español de Trabajo en Enfermedad Inflamatoria Intestinal (GETECCU), Sociedad Española de Obesidad (SEEDO), Asociación Española de Cirugía (AEC) y Sociedad Española de Endoscopia Digestiva (SEED)
Eugeni Domènech, Andreea Ciudin, José María Balibrea, Eduard Espinet-Coll, Fiorella Cañete, Lilliam Flores, Manuel Ferrer-Márquez, Román Turró, ... en nombre del Grupo de Consenso GETECCU-SEEDO-AEC-SEED
10.1016/j.gastrohep.2023.12.008
Available online 22 February 2024
Duration of smoking cessation in patients with inflammatory bowel disease
Carlos González-Muñoza, Cristina Gely, Jordi Gordillo, Federico Bertoletti, Antonio Giordano, Alberto López-Faba, Esther García-Planella
10.1016/j.gastrohep.2023.11.002
Available online 20 February 2024
Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study
Iago Rodríguez-Lago, Fiorella Cañete, Elena Guerra-del-Río, Claudia Herrera-deGuise, Eva Iglesias, Eduardo Leo, Yamile Zabana, Manuel Barreiro-de Acosta, ... José Luis Cabriada
10.1016/j.gastrohep.2024.01.004
Available online 15 February 2024
Brief guidelines for beginners on how to perform and analyze esophageal high-resolution manometry
Andrés R. Latorre-Rodríguez, Sumeet K. Mittal
10.1016/j.gastrohep.2024.01.003
Available online 13 February 2024
Influence of HLA-DQA1*05 on the loss of response to anti-TNF treatment in inflammatory bowel disease. Spanish cohort of real clinical practice
Jorge Pérez Pérez, Jaime Escobar Ortiz, Ana Isabel Franco Moreno, María del Rocío Plaza Santos, Marta Castillo Pradillo, Ángel Ponferrada Díaz
10.1016/j.gastrohep.2024.01.005
Available online 13 February 2024
A meta-analysis of Lactate Ringer's solution versus Normal Saline in the treatment of acute pancreatitis
Zhengwang Wang, Keru Shi, Shaojian Mo, Ziang Liu, Jie Yao
10.1016/j.gastrohep.2023.12.007
Available online 8 February 2024
Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital
Cristina Suárez Ferrer, Eduardo Martin-Arranz, María Dolores Martín-Arranz
10.1016/j.gastrohep.2024.01.002
Available online 5 February 2024
Publish in
Gastroenterología y Hepatología
Special content about COVID-19
- Implicaciones pronósticas de las alteraciones de la bioquímica hepática en los pacientes hospitalizados por COVID-19
- Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina
- Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII)
- A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Free access articles
Gastroenterol Hepatol. 2022;45:304-14
Gastroenterol Hepatol. 2022;45:231-48
Gastroenterol Hepatol. 2022;45:9-17
Gastroenterología y Hepatología follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals